Mahathir Bayena

Ceva (NASDAQ:CEVA) revealed Q2 2026 revenue of $29 million, up 13% year over year, as licensing and related revenue increased to $18.2 million.

Dole (NYSE:DOLE) reported Q2 2026 revenue of $2.499 billion, up 2.9%, while net income increased to $35.1 million from $18 million.

Oculis (NASDAQ:OCS) signed an agreement to acquire worldwide development and commercial rights to Privosegtor (ACT-01) from Accure Therapeutics, along with rights to an early-stage neurology candidate known as ACT-02.

The UK Financial Conduct Authority is developing a tokenised gold framework with major banks, according to a report.

Tambourah Metals (ASX:TMB) released an exploration and financial update detailing a cash position of close to $5 million.

Bitcoin (CRYPTO:BTC) rose above US$65,000 as investors waited for US inflation data due later this week.

Bybit has received support from a US court to trace funds linked to a US$1.5 billion crypto hack.

ReNerve (ASX:RNV) secured marketing approval from India’s Central Drugs Standard Control Organisation for its NervAlign Nerve Cuff.

Arthur Hayes said Bitcoin (CRYPTO:BTC) could fall to US$50,000 before reaching much higher price levels.

Hardware wallet sales in Russia have more than doubled ahead of proposed crypto regulation, according to a report.